Since the PI3K/AKT pathway can regulate VEGFA and influence tumor angiogenesis38, and VEGF promotes ovarian cancer progression and platinum resistance39, FAM172A-mediated PI3K/AKT activation may indirectly affect angiogenesis and treatment response. The gene discussed is AKT1; the disease is ovarian carcinoma.